Optic Nerve Dysfunction in a Mouse Model of Neurofibromatosis-1 Optic Glioma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/NEN.0b013e3181a3240bPMID 19525901PMCID PMC2746323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Müller glia factors induce survival and neuritogenesis of peripheral and central neurons.

  2008cited by this paper
• Gliomas in Neurofibromatosis Type 1: A Clinicopathologic Study of 100 Patients

  2008cited by this paper
• Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.

  2008cited by this paper
• Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings

  2008influential reference
• Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.

  2008cited by this paper
• Cyan fluorescent protein expression in ganglion and amacrine cells in a thy1-CFP transgenic mouse retina

  2008cited by this paper
• Neurturin-Mediated Ret Activation Is Required for Retinal Function

  2008cited by this paper
• Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.

  2007cited by this paper
• Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.

  2007cited by this paper
• Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms.

  2007cited by this paper
• Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.

  2007cited by this paper
• Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• WHO classification of tumours of the central nervous system

  2007cited by this paper
• Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology.

  2007cited by this paper
• The 2007 WHO classification of tumours of the central nervous system

  2007cited by this paper
• Differential sensitivity of in vivo and ex vivo diffusion tensor imaging to evolving optic nerve injury in mice with retinal ischemia

  2006cited by this paper
• The visual evoked potential in the mouse--origins and response characteristics.

  2006cited by this paper
• Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?

  2006influential reference
• Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.

  2005cited by this paper
• Natural history of neurofibromatosis 1–associated optic nerve glioma in mice

  2005cited by this paper
• Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.

  2005cited by this paper
• Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation

  2005cited by this paper
• Demyelination increases radial diffusivity in corpus callosum of mouse brain

  2005cited by this paper
• Pten Loss Causes Hypertrophy and Increased Proliferation of Astrocytes In vivo

  2004cited by this paper
• A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas.

  2004cited by this paper
• Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system.

  2004influential reference
• Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.

  2003cited by this paper
• Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment

  2002cited by this paper
• Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma Formation

  2002cited by this paper
• Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus

  2001cited by this paper
• Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis.

  2001cited by this paper
• Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.

  2001cited by this paper
• Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.

  2000cited by this paper
• The Major Cell Populations of the Mouse Retina

  1998cited by this paper
• Toward a quantitative assessment of diffusion anisotropy

  1996cited by this paper
• Hypoxic and excitotoxic damage to cultured rat retinal ganglion cells.

  1996cited by this paper
• Neurofibromatosis type 1.

  1995cited by this paper
• Neurofibromatosis type 1.

  1995cited by this paper
• Precocious puberty in children with neurofibromatosis type 1.

  1995cited by this paper
• Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

  1994cited by this paper
• Neurofibromatosis: Phenotype, Natural History, and Pathogenesis

  1993cited by this paper
• Neurofibromatosis: Phenotype, Natural History and Pathogenesis

  1993cited by this paper
• Neurofibromatosis: past, present, and future.

  1991cited by this paper
• Growth of adult rat retinal ganglion cell neurites on astrocytes

  1990cited by this paper
• Optic gliomas in children with neurofibromatosis type 1.

  1989cited by this paper
• Effects of cultured astroglia on the survival of neonatal rat retinal ganglion cells in vitro.

  1984cited by this paper

• Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1)

  2025cites this paper
• An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies

  2024cites this paper
• Longitudinal changes in retinal ganglion cell function in optic pathway glioma evaluated by photopic negative response.

  2024cites this paper
• Optic Pathway Gliomas: The Trends of Basic Research to Reduce the Impact of the Disease on Visual Function.

  2023cites this paper
• The role of visual electrodiagnostics in management of children with neurofibromatosis type 1

  2023cites this paper
• The Neuroimmune Regulation and Potential Therapeutic Strategies of Optic Pathway Glioma

  2023cites this paper
• Insights into Novel Choroidal and Retinal Clinical Signs in Neurofibromatosis Type 1

  2023cites this paper
• A systematic review and meta‐analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1

  2022cites this paper
• Neuroretinal Dysfunction in Patients Affected by Neuro�bromatosis Type 1

  2021cites this paper
• Neuroretinal dysfunction in patients affected by neurofibromatosis type 1.

  2021cites this paper
• Comparison of multi-shot and single shot echo-planar diffusion tensor techniques for the optic pathway in patients with neurofibromatosis type 1

  2019cites this paper
• Brain tumors in neurofibromatosis type 1

  2019cites this paper
• Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1

  2019cites this paper
• Optic Pathway Gliomas in Neurofibromatosis Type 1

  2018cites this paper
• Neurofibromin is essential to maintain metabolic function and sustain life in the adult mouse

  2018cites this paper
• Human stem cell modeling in neurofibromatosis type 1 (NF1).

  2018cites this paper
• Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1.

  2017cites this paper
• CNS Tumors in Neurofibromatosis.

  2017cites this paper
• Neurofibromatosis type 1

  2017cites this paper
• Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction

  2016cites this paper
• Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial.

  2016cites this paper
• Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma

  2016cites this paper
• NF 1 germline mutation differentially dictates optic glioma formation and growth in neuro fi bromatosis-1

  2016cites this paper
• NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

  2016cites this paper
• Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.

  2015cites this paper
• Pediatric gliomas as neurodevelopmental disorders

  2015cites this paper
• The impact of coexisting genetic mutations on murine optic glioma biology.

  2015cites this paper
• RASopathies: unraveling mechanisms with animal models

  2015cites this paper
• Functional Loss of the Inner Retina in Childhood Optic Gliomas Detected by Photopic Negative Response.

  2015cites this paper
• Eliminating barriers to personalized medicine

  2014cites this paper
• neurofibromatosis type 1 Eliminating barriers to personalized medicine: Learning from

  2014cites this paper
• Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1

  2014cites this paper
• Neurofibromatosis type 1 (NF1): diagnosis and management.

  2013cites this paper
• Modeling cognitive dysfunction in neurofibromatosis-1.

  2013cites this paper
• Visual function and optic pathway glioma: a critical response.

  2013cites this paper
• Enhanced Retinal Ganglion Cell Survival in Glaucoma by Hypoxic Postconditioning After Disease Onset

  2013cites this paper
• Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.

  2013cites this paper
• Using Genetically Engineered Mouse Models to Understand Low-Grade Glioma Development and Growth in Children

  2012cites this paper
• Pediatric Low-Grade Glioma: The Role of Neurofi bromatosis-1 in Guiding Therapy

  2012cites this paper
• Low‐grade gliomas as neurodevelopmental disorders: insights from mouse models of neurofibromatosis‐1

  2012cites this paper
• Translational/Clinical Studies in Children and Adults with Neurofibromatosis Type 1

  2012cites this paper
• NF1-Associated Optic Glioma

  2012cites this paper
• Chapter 31 Mouse Phenotyping with MRI

  2011cites this paper
• Mouse phenotyping with MRI.

  2011cites this paper
• Neurofibromatosis-1 Heterozygosity Increases Microglia in a Spatially and Temporally Restricted Pattern Relevant to Mouse Optic Glioma Formation and Growth

  2011cites this paper
• Nerve Growth Factor Eye Drop Administration Improves Visual Function in a Patient With Optic Glioma

  2011influential citation
• The ecology of brain tumors: lessons learned from neurofibromatosis-1

  2011cites this paper
• Optic Pathway Gliomas

  2011cites this paper
• Molecular genetics of optic glioma: lessons learned from neurofibromatosis-1 genetically engineered mice

  2011cites this paper
• Defective cAMP Generation Underlies the Sensitivity of CNS Neurons to Neurofibromatosis-1 Heterozygosity

  2010influential citation
• Screening children with NF1 for optic pathway glioma – Yes

  2010cites this paper
• Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.

  2010influential citation
• DefectivecAMPGenerationUnderliestheSensitivityof CNSNeuronstoNeurofibromatosis-1Heterozygosity

  2010cites this paper
• Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations

  2007cites this paper